Volume 18, Number 3—March 2012
Dispatch
Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008
Xiaomeng Wang, Qian Fu, Zhijun Li, Songhua Chen, Zhengwei Liu, Hugh Nelson, Qun Yang, Zhongwei Jia
, and Christopher Dye
, and Christopher DyeTable 1
Resistance to 2 TB drugs, by patient age, sex, and treatment status in Zhejiang Province, China, 1999, 2004, and 2008*
| Year, group |
No. (%) patients
|
|||
|---|---|---|---|---|
| Total | Isoniazid | Rifampin | MDR | |
| 1999 | ||||
| Total | 1,013 | 138 (13.6) | 116 (11.5) | 87 (8.6) |
| Patients 0–14 years of age | 12 (1.2) | 1 (8.3) | 1 (8.3) | 1 (8.3) |
| Patients 15–64 year of age | 808 (79.8) | 120 (14.9) | 97 (12.0) | 78 (9.7) |
| Patients >65 years of age | 193 (19.1) | 17 (8.8) | 17 (8.8) | 8 (4.2) |
| Male patients | 723 (71.4) | 100 (13.8) | 81 (11.2) | 60 (8.3) |
| Female patients | 290 (28.6) | 38 (13.1) | 35 (12.1) | 27 (9.3) |
| New cases | 841 (83.0) | 72 (8.6) | 51 (6.1) | 35 (4.2) |
| Re-treatment cases | 172 (16.9) | 66 (38.4) | 65 (37.8) | 52 (30.2) |
| 2004 | ||||
| Total | 984 | 159 (16.2) | 94 (9.6) | 75 (7.6) |
| Patients 0–14 years of age | 3 (0.3) | 1 (33.3) | 1 (33.3) | 1 (33.3) |
| Patients 5–64 years of age | 764 (77.6) | 125 (16.4) | 74 (9.7) | 58 (7.6) |
| Patients >65 years of age | 217 (22.1) | 33 (15.2) | 19 (8.8) | 16 (7.4) |
| Male patients | 730 (74.2) | 125 (17.1) | 73 (10.0) | 61 (8.4) |
| Female patients | 254 (25.8) | 34 (13.4) | 21 (8.3) | 14 (5.5) |
| New cases | 831 (84.5) | 102 (12.3) | 41 (4.9) | 30 (3.6) |
| Re-treatment cases | 153 (15.6) | 57 (37.3) | 53 (34.6) | 45 (29.4) |
| 2008 | ||||
| Total | 938 | 125 (13.3) | 75 (8.0) | 56 (6.0) |
| Patients 0–14 years of age | 5 (0.5) | 0 | 1 (20.0) | 0 |
| Patients 15–64 years of age | 756 (80.6) | 103 (13.6) | 63 (8.3) | 48 (6.4) |
| Patients >65 years of age | 177 (18.9) | 22 (12.4) | 11 (6.2) | 8 (4.5) |
| Male patients | 646 (68.9) | 91 (14.1) | 55 (8.5) | 40 (6.2) |
| Female patients | 292 (31.1) | 34 (11.6) | 20 (6.9) | 16 (5.5) |
| New cases | 842 (89.8) | 88 (10.5) | 43 (5.1) | 28 (3.3) |
| Re-treatment cases | 96 (10.2) | 37 (38.5) | 32 (33.3) | 28 (29.2) |
*TB, tuberculosis; MDR, multidrug resistant.
